Published the 1 March 2019Invent Medic announces that a post-launch study with the company’s medical technology product Efemia Bladder Support showed a significant improvement in quality of life in women with self-diagnosed stress urinary incontinence. The study was conducted together with...
Regulatory
Published the 22 February 2019The Board of Directors and the CEO reports the following for the fiscal year 2018. Unless otherwise stated, all amounts are reported in integers SEK (SEK). Data in parentheses refer to the previous year. Summary of the year-end report TWELVE MONTHS (January –...
Regulatory
Published the 19 February 2019Invent Medic has today signed an agreement with Copenhagen-based Props & Pearls covering the right to market and sell the Arcamea-product Efemia bladder support to health care entities and end-customers in Denmark. The product will be launched in Q1 2019. Invent...
Published the 19 February 2019Invent Medic announces that Kerstin Wäborg has been recruited as Head of Sales of Invent Medic and Arcamea. Wäborg has extensive experience from positions as Product Specialist, Head of Sales and Head of Products at the Nordic part of Novo Nordisk, Abbott,...
Regulatory
Published the 4 February 2019Invent Medic has today signed an agreement with Sweden’s largest pharmacy chain, Apoteket AB, that has agreed to include the company’s product Efemia bladder support in its assortment. Initially, Efemia will be available in Apoteket’s nationwide webshop Apoteket.se....
Published the 18 December 2018Invent Medic announces that the company will increase and strengthen its market communication together with the IR communication agency Honeybadger. The collaboration includes a strategic communication plan as well as ongoing and periodic communication. As a part of...
